From: Apolipoprotein C-III in patients with systemic lupus erythematosus
SLICC | Katz index | SLEDAI | |
---|---|---|---|
Beta coef. (95% CI), p | |||
Lipid profile | |||
Cholesterol, mg/dl | 0.3 (− 2–3), 0.84 | − 0.06 (− 3–3), 0.97 | 1 (0–2), 0.17 |
Triglycerides, mg/dl | 2 (− 4–8), 0.59 | − 1 (− 7–6), 0.83 | − 1 (− 3–2), 0.63 |
HDL cholesterol, mg/dl | 0.1 (− 1–2), 0.88 | 1 (0–3), 0.12 | 1 (0–1), 0.11 |
LDL cholesterol, mg/dl | − 0.2 (− 2–2), 0.89 | − 1 (− 3–1), 0.30 | 0.4 (0–1), 0.36 |
LDL:HDL cholesterol ratio | 0.02 (− 0.4–0.07), 0.50 | − 0.05 (− 0.11–0.01), 0.080 | − 0.005 (− 0.03–0.02), 0.67 |
Non-HDL cholesterol, mg/dl | 0.3 (− 2–3), 0.85 | 0.01 (− 3–3), 0.99 | 1 (0–2), 0.16 |
Apolipoprotein A1, mg/dl | 1 (− 2–3), 0.66 | 2 (− 1–5), 0.25 | 1 (0–2), 0.068 |
Apolipoprotein B, mg/dl | − 1 (− 2–1), 0.48 | − 0.2 (− 2–2), 0.82 | 0.2 (− 1–1), 0.59 |
Apo B: A1 ratio | − 0.004 (− 0.2–0.01), 0.49 | − 0.01 (− 0.02–0.00), 0.22 | 0.0009 (− 0.01–0.00), 0.73 |
Lipoprotein (a), mg/dl | − 3 (− 9–4), 0.41 | 0.5 (-6–7), 0.89 | 1 (− 2–3), 0.67 |
Atherogenic index | 0.04 (− 0.04–0.12), 0.38 | − 0.06 (− 0.14–0.02), 0.16 | − 0.01 (− 0.04–0.02), 0.48 |
Apolipoprotein C3, mg/dl | |||
Unadjusted | 0.14 (0.06–0.23), 0.001 | 0.10 (0.01–0.19), 0.030 | 0.02 (− 0.01–0.06), 0.19 |
Adjusted #1 | 0.10 (0.02–0.19), 0.020 | 0.10 (0.02–0.19), 0.015 | 0.04 (0.00–0.07), 0.036 |
Adjusted #2 | 0.11 (0.03–0.19), 0.011* | 0.05 (0.02–0.08), 0.004** |